This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
Associated British Foods (ABF.L) – Total sales at Primark climbed 11% in the 16 week Christmas period as it stuck to a forecast to make progress in group annual operating profit. In the UK, it reported “good” underlying sales and said stock was well-managed in the period. Outlook for the year was unchanged. Closing Price 2698p (Reuters)
AstraZeneca (AZN.L), GlaxoSmithKline (GSK.L), Shire (SHP.L) – Donald Trump attacks Pharmaceutical industry stating “They are getting away with murder” leading to $24bn wiped from American companies within minutes. Closing Price 4577p, 1581.50p, 4681.50p (CNBC)
ASOS (ASC.L) – International sales increased by 52% to £362m ($742m) in the four months to the end of December, with sales in its home market up by 18% to £244m. Closing Price 5389p (Reuters)
Barratt Developments (BDEV.L) – H1 Total completions fall 6% to 7180, average selling price to £264,000. Forward sales including joint ventures up 15.8% to £2.34bn, on track to deliver on volume guidance for the full year. Closing Price 501p (Reuters)
Marks and Spencer (MKS.L) – Clothing & Home like-for-like sales rose 2.3% in the 13 Weeks to 31 Dec, beating a market forecast of a rise of 0.2%, while food was up 0.6%, also ahead of forecasts. Closing Price 340.40p (Reuters)
Premier Oil (PMO.L) – Said full-year revenue slipped 10% year-on-year in preliminary results, despite production levels hitting an improved target. Closing Price 91.50p Reuters
Tesco (TSCO.L) – On track to deliver £1.2bn adjusted operating profit for the year. Third quarter like for like sales growth up 1.5%. Like for like sales for the six weeks ending 7th Jan up 0.3%. Closing Price 208.80p (Reuters)
For more information on any of these individual news items, call into the trading floor
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research